This review determines the contraindications, validates the correct dose and makes sure that the treatment is in line with the current health conditions of the patient
Unlike many peptides that are unstable in physiological conditions, BPC-157 has demonstrated remarkable stability in both acidic (gastric) and neutral (plasma) environments in published research a property that has made it one of the most studied peptides for tissue repair across more than 100 independent pre-clinical investigations
In 2023, the FDA placed 19 peptides in Category 2, which already included a handful of substances the agency considered to be dangerous
This may improve its stability and support healthy glutathione levels within the body
US 8598118, Harding JW, Wright JW, Benoist CC, Kawas LH, Wayman GA, "Hepatocyte growth factor mimics as therapeutic agents", issued 3 December 2013 "Facilitation of hippocampal synaptogenesis and spatial memory by C-terminal truncated Nle1-angiotensin IV analogs"